European Innovation Council

Patient-specific right heart pumps that free patients from heavy battery packages and increase patient's quality of life.

RespiQ is a healthtech startup that specializes in portable, non-invasive breath analysis technology aimed at the early detection and management of respiratory diseases. By utilizing advanced emission spectroscopy and artificial intelligence, RespiQ's device identifies volatile organic compounds (VOCs) in breath, enabling real-time detection of conditions such as COPD exacerbations. The company's focus on affordability, portability, and user-friendliness seeks to democratize access to advanced diagnostics, ultimately improving patient outcomes and reducing healthcare costs. In addition to respiratory diseases, RespiQ's versatile platform has potential applications for asthma, lung cancer, and infectious diseases. The company also offers an app that provides personalized health insights and dietary guidance, allowing users to monitor their health proactively. RespiQ's combination of technical and healthcare expertise positions it as a leader in breath diagnostics, with a commitment to enhancing overall health and well-being.

GrayMatters Health is a health technology company focused on developing digital therapeutics aimed at addressing mental disorders through the regulation of brain processes. By utilizing an approach grounded in neuroscience, the company provides solutions that enhance the efficacy, safety, and accessibility of mental healthcare. Their offerings empower healthcare professionals and patients alike, enabling individuals with neurological disorders to manage their conditions more effectively and conveniently. GrayMatters Health aims to bridge existing gaps in mental health treatment, promoting better outcomes for those affected by these challenges.

VIVAN Therapeutics is a company focused on transforming cancer care through personalized therapeutics. It utilizes a novel assay technology licensed from the Center for Personalized Cancer Therapeutics at Mt Sinai New York, which enables the development of tailored treatment strategies. The company's approach involves the Personal Discovery Process (PDP), a unique clinical trial method designed for individual patients. This process analyzes the genetic complexity of each patient's tumor by engineering it into fruit flies, allowing for the evaluation of both FDA-approved cancer and non-cancer drugs. VIVAN Therapeutics aims to provide less toxic and more affordable treatment options by recommending combinations of these drugs, thereby enhancing the effectiveness of cancer therapies. The company is also working on new diagnostics and decision support tools to improve treatment outcomes for cancer patients.

Brainhero is a life science company that specializes in home-based neurofeedback therapy aimed at addressing neurological impairments, particularly Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD). The company offers a playful approach to brain training, allowing children to learn how to control their brain activity through the measurement of brain waves using electroencephalogram (EEG) technology. This data is visualized in a user-friendly app, facilitating an engaging experience for young users. Brainhero's services extend beyond ASD and ADHD to include other neurological issues such as intellectual disabilities, epilepsy, and anxiety. Additionally, the company provides mobile neurofeedback training that helps improve concentration and relaxation, assisting medical practitioners in early detection of neurological problems and supporting appropriate medication management for patients.

Restore Medical is a medical device company focused on treating congestive heart failure, specifically targeting patients with left ventricle failure. Founded in 2016 and based in Or Yehuda, Israel, the company offers ContraBand, a catheter-delivered implant designed for placement in the pulmonary arteries. This innovative device aims to enhance left ventricle ejection fraction, decrease mitral regurgitation, and restore favorable ventricular geometry. By improving patient outcomes, Restore Medical's solutions contribute to a better quality of life and aim to reduce the rates of hospital readmission among affected individuals.

NeuoKaire, previously known as Genetika+, is focused on advancing personalized medical testing for the treatment of depression. The company has developed a platform that utilizes biological, medical, and genetic data, along with innovative technology, to identify the most effective drug therapies for individual patients. This approach aims to facilitate faster treatment, minimize side effects, and reduce dosages. By assisting pharmaceutical companies in differentiating their products and de-risking clinical trials, NeuoKaire enhances the identification of responsive patients and improves stratification. The integration of stem-cell technology, genomics, and artificial intelligence further supports the optimization of treatments for psychiatric and neurological disorders, ultimately aiming to transform care and improve patient outcomes.

GrayMatters Health is a health technology company focused on developing digital therapeutics aimed at addressing mental disorders through the regulation of brain processes. By utilizing an approach grounded in neuroscience, the company provides solutions that enhance the efficacy, safety, and accessibility of mental healthcare. Their offerings empower healthcare professionals and patients alike, enabling individuals with neurological disorders to manage their conditions more effectively and conveniently. GrayMatters Health aims to bridge existing gaps in mental health treatment, promoting better outcomes for those affected by these challenges.

Askel Healthcare is a medical device company focused on improving knee cartilage repair and recovery. The company offers a science-backed solution designed to rebuild the knee joint surface, facilitating a quicker return to an active and pain-free life. Its innovative device provides evidence-based solutions that address cartilage repair and the prevention of osteoarthritis, not only in human medicine but also in veterinary applications. This dual approach enables healthcare providers to treat a larger number of patients efficiently while minimizing complications and reducing costs, ultimately fostering faster rehabilitation.

Xsensio is a digital health company focused on addressing the challenge of real-time, continuous monitoring of health parameters. It is developing an innovative Lab-on-Skin wearable device that serves as a miniaturized sensing platform, enabling continuous and real-time analysis of biochemical information at the skin's surface. This technology allows for the precise measurement of various health indicators, such as electrolytes, metabolites, hormones, and proteins, akin to traditional blood tests but in a minimally invasive manner. By providing unprecedented insights during critical health events, Xsensio aims to enhance patient care and shift the healthcare industry from a static to a dynamic approach in health monitoring.

AVeta Medical specializes in developing biotechnology medical devices aimed at providing safe and affordable treatments for vaginal atrophy. The company focuses on hormone-free solutions that address the underlying conditions associated with this condition. Its innovative devices offer a natural approach to treatment, allowing women to recover and repair their bodies without the use of drugs or hormonal therapies. By prioritizing science-backed methods, AVeta Medical aims to improve the quality of life for women experiencing vaginal atrophy.

GrayMatters Health is a health technology company focused on developing digital therapeutics aimed at addressing mental disorders through the regulation of brain processes. By utilizing an approach grounded in neuroscience, the company provides solutions that enhance the efficacy, safety, and accessibility of mental healthcare. Their offerings empower healthcare professionals and patients alike, enabling individuals with neurological disorders to manage their conditions more effectively and conveniently. GrayMatters Health aims to bridge existing gaps in mental health treatment, promoting better outcomes for those affected by these challenges.

PKVitality is a bio-wearable company based in Paris, France, that specializes in developing innovative health monitoring devices. Its flagship product, K'Watch Glucose, is a smartwatch-style continuous glucose monitoring device that employs a micro-needle sensor to allow diabetics to monitor their glucose levels painlessly and discreetly. This wearable tracker is designed to provide real-time data without the need for calibration, offering a complete history of glucose levels and sending alerts for potential hypo or hyperglycemia episodes. Additionally, PKVitality is expanding its product line to include a Continuous Lactate Monitor and multi-analyte continuous monitors, which will further enhance the capabilities of their health monitoring technology. Founded in 2017, PKVitality aims to simplify health management for individuals, particularly those with diabetes, by eliminating the discomfort associated with traditional blood tests.

Exeliom is a clinical-stage biopharmaceutical company based in Dijon, France, focused on developing innovative microbial therapies that utilize commensal bacteria as therapeutic agents. Founded in 2016, Exeliom aims to unlock the therapeutic potential of gut microbiota to enhance health and longevity. The company specializes in creating a new class of medicines known as Live Biotherapeutics, which are designed to deliver microbiome-based immunotherapy for conditions such as inflammatory bowel diseases and cancer, with an initial focus on Crohn's Disease. By harnessing the role of microbiota in the immune system, Exeliom strives to provide patients with advanced treatments that improve their quality of life.

PKVitality is a bio-wearable company based in Paris, France, that specializes in developing innovative health monitoring devices. Its flagship product, K'Watch Glucose, is a smartwatch-style continuous glucose monitoring device that employs a micro-needle sensor to allow diabetics to monitor their glucose levels painlessly and discreetly. This wearable tracker is designed to provide real-time data without the need for calibration, offering a complete history of glucose levels and sending alerts for potential hypo or hyperglycemia episodes. Additionally, PKVitality is expanding its product line to include a Continuous Lactate Monitor and multi-analyte continuous monitors, which will further enhance the capabilities of their health monitoring technology. Founded in 2017, PKVitality aims to simplify health management for individuals, particularly those with diabetes, by eliminating the discomfort associated with traditional blood tests.

Weber Hospital Systems is a company that specializes in developing solutions to help minimize healthcare-associated infections (HAIs) in hospitals. By developing innovative solutions to help reduce the risk of HAIs, Weber Hospital Systems is likely to play an important role in improving patient outcomes and overall hospital safety. Their solutions include a range of products such as disinfectant systems, air filtration systems, and surface coatings that are designed to eliminate or reduce the presence of harmful pathogens in the hospital environment. One of the company's flagship products is the Weber Mediclean System, a fully automated disinfection system that uses UV-C light to kill bacteria and viruses on hospital surfaces. This system is designed to be fast and efficient, eliminating up to 99.99% of bacteria and viruses within a matter of minutes. In addition to their disinfection systems, Weber Hospital Systems also offers air filtration systems that use advanced HEPA filtration technology to remove harmful particles and pathogens from the air. Their surface coatings are designed to create a barrier that prevents the growth of bacteria and viruses on hospital surfaces, providing an additional layer of protection against HAIs.

Xsensio is a digital health company focused on addressing the challenge of real-time, continuous monitoring of health parameters. It is developing an innovative Lab-on-Skin wearable device that serves as a miniaturized sensing platform, enabling continuous and real-time analysis of biochemical information at the skin's surface. This technology allows for the precise measurement of various health indicators, such as electrolytes, metabolites, hormones, and proteins, akin to traditional blood tests but in a minimally invasive manner. By providing unprecedented insights during critical health events, Xsensio aims to enhance patient care and shift the healthcare industry from a static to a dynamic approach in health monitoring.

Weber Hospital Systems is a company that specializes in developing solutions to help minimize healthcare-associated infections (HAIs) in hospitals. By developing innovative solutions to help reduce the risk of HAIs, Weber Hospital Systems is likely to play an important role in improving patient outcomes and overall hospital safety. Their solutions include a range of products such as disinfectant systems, air filtration systems, and surface coatings that are designed to eliminate or reduce the presence of harmful pathogens in the hospital environment. One of the company's flagship products is the Weber Mediclean System, a fully automated disinfection system that uses UV-C light to kill bacteria and viruses on hospital surfaces. This system is designed to be fast and efficient, eliminating up to 99.99% of bacteria and viruses within a matter of minutes. In addition to their disinfection systems, Weber Hospital Systems also offers air filtration systems that use advanced HEPA filtration technology to remove harmful particles and pathogens from the air. Their surface coatings are designed to create a barrier that prevents the growth of bacteria and viruses on hospital surfaces, providing an additional layer of protection against HAIs.

MoveUP is a company focused on developing and commercializing digital therapeutics solutions designed to enhance healthcare delivery. Its innovative platform features a closed-loop system that ensures high compliance and improved outcomes for patients. By continuously collecting data, the platform personalizes treatment plans, significantly enhancing patient satisfaction. MoveUP's initial product targets orthopedic patients recovering from joint surgery, providing a user-friendly medical-grade mobile application that supports faster recovery. The company holds CE medical device and ISO 13485 certifications, underscoring its commitment to quality and regulatory standards in the healthcare sector.

MoveUP is a company focused on developing and commercializing digital therapeutics solutions designed to enhance healthcare delivery. Its innovative platform features a closed-loop system that ensures high compliance and improved outcomes for patients. By continuously collecting data, the platform personalizes treatment plans, significantly enhancing patient satisfaction. MoveUP's initial product targets orthopedic patients recovering from joint surgery, providing a user-friendly medical-grade mobile application that supports faster recovery. The company holds CE medical device and ISO 13485 certifications, underscoring its commitment to quality and regulatory standards in the healthcare sector.

Xsensio is a digital health company focused on addressing the challenge of real-time, continuous monitoring of health parameters. It is developing an innovative Lab-on-Skin wearable device that serves as a miniaturized sensing platform, enabling continuous and real-time analysis of biochemical information at the skin's surface. This technology allows for the precise measurement of various health indicators, such as electrolytes, metabolites, hormones, and proteins, akin to traditional blood tests but in a minimally invasive manner. By providing unprecedented insights during critical health events, Xsensio aims to enhance patient care and shift the healthcare industry from a static to a dynamic approach in health monitoring.

Picterus is developing a smartphone application aimed at diagnosing jaundice in newborns, a condition that contributes to over 100,000 deaths annually, particularly in impoverished areas of Sub-Saharan Africa and South Asia. Existing screening devices are prohibitively expensive, often costing around $7,000, which limits access in low-resource settings. The app utilizes patented biomedical optics technology to provide accurate estimates of jaundice levels while accounting for variations in skin pigmentation. This innovation addresses the growing need for affordable and effective diagnostic tools, especially given the trend of shorter hospital stays post-birth and the rising rates of jaundice-related hospital readmissions. By enabling parents to monitor their child's jaundice levels at home, Picterus aims to improve health outcomes for vulnerable populations.